Evidence map›Paper›PMID 40873445›Full record

ArticleFrontiers in nutrition2025

Quantitative screening of geranylgeranoic acid in selected plant-based foods using LC/MS/MS.

Yuki Tabata

Abstract read
In one paragraph

Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Yuki TabataDepartment of Nutritional Health, Nutritional Biochemistry, Faculty of Wellness Studies, Kwassui Women's University, Nagasaki, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Geranylgeranoic acid (GGA), a bioactive acyclic isoprenoid, has been developed as a preventive agent against recurrent hepatocellular carcinoma. While previous studies have identified GGA in certain medicinal herbs, such as turmeric, its presence in other commonly consumed plant-based foods remains largely unexplored. In this study, we screened 14 plant-based food items using a validated LC/MS/MS method to quantify their GGA content. Among the tested samples, turmeric powder exhibited the highest GGA concentration (20.2 ± 8.25 ng/g dry weight), consistent with previous findings. GGA was also detected in several nuts, including almonds (Italy: 7.59 ± 2.45 ng/g; USA: 6.48 ± 1.28 ng/g), cashew nuts (4.12 ± 1.12 ng/g), and pistachios (3.48 ± 0.95 ng/g). Importantly, azuki beans (7.21 ± 2.12 ng/g) and soybeans (1.21 ± 0.29 ng/g) were also found to contain GGA, suggesting that some legumes may serve as additional dietary sources of this compound. In contrast, GGA was not detected above the limit of quantification for the following seven items: chickpea, walnut, sesame seeds, and dried parsley. These negative results are also informative for defining the boundaries of GGA distribution in plant-based foods. This study provides new data on the occurrence of GGA in plant-derived foods and contributes to a comprehensive understanding of its potential dietary sources.

Indexed as

cancer chemopreventiondietary isoprenoidsgeranylgeranoic acidhepatic carcinogenesisLC/MS/MSlipid mediatorsnutritional biochemistryplant-derived compounds

Identifiers

PMID40873445
PMCPMC12378757

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.